Demand for life science space in Boston shows no signs off slowing as Vertex Pharmaceuticals confirmed it plans to occupy a new 344,000-square-foot facility to be built across the street from its just-opened cell and genetic therapy research and manufacturing facility in Boston’s Seaport District.
Pharmaceutical Firm Makes Bid To Become Boston's Biggest Biotech
Life Science Feeding Frenzy Shows No Signs of Slowing As Vertex Discloses More Seaport District Plans
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Innovation Square
20-22 Drydock Ave, Boston, MA
- ISQ Seaport Phase II
316 Northern Ave, Boston, MA
- Companies
- Related Beal
Real Estate